Ascletis and Alphamab Announce Strategic Collaboration and Licensing Agreement for Anti-PD-L1 to Treat Hepatitis B and Other Viral Diseases
2019-01-14Ascletis Presented at the LeadingBiotech: East/West CEO
2019-01-07Ascletis' IND Filing for Its Third HCV Innovative Drug ASC21 Accepted by NMPA
2019-01-03Ascletis' Ganovo Enrolled in the Basic Medical Insurance of Chengdu
2019-01-02
